- Home
- WHWK
WHWK
Whitehawk Therapeutics Inc. Common Stock
as 06-05-2025 4:00pm EST
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 48.3M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 99.0K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.91 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.21 - $3.81 | Next Earning Date: | 05-08-2025 |
| Revenue: | $27,775,000 | Revenue Growth: | 16.51% |
| Revenue Growth (this year): | 40.15% | Revenue Growth (next year): | N/A |
Latest Whitehawk Therapeutics Inc. Common Stock News
WHWK Breaking Stock News: Dive into WHWK Ticker-Specific Updates for Smart Investing
PR Newswire
9 days ago
Whitehawk Therapeutics to Present at the Jefferies 2025 Global Healthcare Conference
PR Newswire
16 days ago
Whitehawk Therapeutics to Participate in the TD Cowen 6th Annual Oncology Innovation Summit
PR Newswire
a month ago
Whitehawk Reports First Quarter 2025 Financial Results and Recent Highlights
Compare WHWK vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "WHWK Whitehawk Therapeutics Inc. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.